Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Processed 2,841 EsoGuard tests and recognized 3Q25 revenue of $1.2 million, ending quarter with over $47 million in proforma cash and extending runway through 2026 and well past up…
